- Display 15 Products per page
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition
Published: August 13, 2014 | Price: $1,995.00 – $3,990.00
The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies. It's often necessary for competitors to know about all of the segments of testing as different technologies can...
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
Published: February 1, 2010 | Price: $2,500.00 – $5,000.00
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Clinical laboratories are an essential part of the health industry. Kalorama Information estimates that approximately 80% of physicians' diagnoses are a result of laboratory tests.he constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role...
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...
Who’s Doing What in Molecular Diagnostics ? – The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories
Published: April 1, 2009 | Price: $1,500.00 – $9,990.00
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...
World Market for Molecular Diagnostics, 3rd. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
Published: January 1, 2009 | Price: $3,995.00 – $7,990.00
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine. From Emerging to Emergent Technology Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. At each step of the way, Kalorama Information has reported on its progress, and in this latest market research...
Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics
Published: August 1, 2008 | Price: $2,995.00 – $5,000.00
A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies and quantifies in greater detail some of the important areas that will have a transforming impact on the diagnostic industry: • Companies are now performing diagnostic tests as a service rather than simply selling kit to laboratories. Are companies seeking profit, or a 'back-door' around FDA regulations? And does it have growth...
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in ‘Theranostics’ and Personalized Medicine)
Published: June 1, 2008 | Price: $2,995.00 – $5,990.00
This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as a pathway to personalized medicine, where the right therapeutic is...
Clinical Diagnostics in India – Market Sector Analyses and Participant Directory
Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...
Molecular Imaging Agents and Systems – A Market Briefing
Published: June 1, 2005 | Price: $995.00 – $1,990.00
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...
Cell-Based Diagnostics: Technology, Applications, and Markets
Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples, the complete blood count, and the enumeration of disease-bearing cells have been...
Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential
Published: October 1, 2004 | Price: $995.00 – $1,990.00
Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...
Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential
Published: October 1, 2004 | Price: $995.00 – $1,990.00
Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors. This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing. The major market effects...
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential
Published: October 1, 2004 | Price: $995.00 – $1,990.00
The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part, by his or her genetic constitution. Differences in drug metabolism may lead to varying adverse events or more pronounced adverse events in different individuals, and differing metabolism may also lead...
U.S. Market for Molecular Diagnostics, 2nd Edition
Published: May 1, 2004 | Price: $3,500.00 – $7,000.00
Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based on molecular testing approaches. The primary molecular diagnostics approaches are based on two major database sciences (genomics and proteomics) and their relationship to disease and...